Medincell | Sustainability Performance
Focused on pharmaceutical or medical solutions.
2003
France
51 - 200 employees
Pharmaceuticals
$25M - 100M in revenue
Sustainability Ranking & Industry Benchmark
#4582
Overall#280
in France#109
in PharmaceuticalsSustainability Maturity
Sustainability Intent
Overview
Environmental
Energy consumptionGovernance
TargetsESG scores and ExclusionsFinancial Data
Business performanceCapital & innovationAnalyst projections
Renewable energy
Critical
Market cap
Revenue
R&D intensity
Renewable electricity
Reveal data for 1 credit
3%2023
Industry rank: 17 out of 312
Total electricity consumption
and % renewables
(MWh, % of consumption)
Industry rank: 17 out of 312
Total electricity
Share of renewable electricity
Industry benchmark
Controversy level
Powered by illuminem
Market cap
Revenue
EBITDA
Operating margin
Revenue & EBITDA
$21.4MFY2026 revenue
Total Annual
Revenue & EBITDA
($ B)
Annual revenue
EBITDA
3 year change
Margin trends
Margin as % of revenue
Gross margin
Operating margin
Net margin
Powered by illuminem
Free cashflow
Capex
Debt/equity ratio
R&D intensity
136.8%FY2026
R&D as % of revenue
Return on invested capital (ROIC)
Industry benchmark
Powered by illuminem
Return on invested capital
-52.0%FY2026
Return on invested capital (ROIC)
Industry benchmark
Powered by illuminem
Analyst revenue estimates & actuals
Analyst consensus vs actuals
($ B)
Actual revenue
Consensus estimates
Estimate only
0.0
▼ 39.1%
0.0
▲ 34.1%
0.0
▼ 39.9%
0.1
2031Powered by illuminem
Environmental policy coverage
Carbon reduction policy
Not available
Human rights policy
Not available
Recycling policy
Not available
Workplace health & safety policy
Not available
38%
Independent Directors
6 out of 16 incl. management
Overall score
0
Environment
0
Social
0
Governance
0
Exclusion screening
Adult content
Not available
Alcoholic
Not available
Animal testing
Not available
Firearms
Not available
Tobacco
Not available
Gambling
Not available
Nuclear
Not available
